Silver Compounds Protect Blood Cells During Chemotherapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Chemotherapy often damages red and white blood cells, leading to reduced counts that can impair a subject's health and recovery, necessitating a method to protect these cells during treatment.
Innovation Solution
The use of silver compounds, specifically silver particles in the form of nano-silver and colloidal silver, is administered to subjects to protect their blood cells by increasing or maintaining red and white blood cell counts before, during, and after chemotherapy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If chemotherapy is administered to treat cancer, then cancerous cells are targeted and destroyed, but red blood cells and white blood cells are damaged and killed, leading to reduced blood cell counts
Solution Approach 1:
The patent introduces silver compounds as an intermediary substance that mediates between chemotherapy and blood cells. The silver compounds selectively protect blood cells from chemotherapy damage through a protective mechanism while allowing chemotherapy to maintain its efficacy against cancer cells, thus resolving the contradiction between treatment effectiveness and blood cell preservation
2Quantity of substance
If silver compounds are administered to protect blood cells, then blood cell counts are increased or maintained, but there is potential concern about interfering with chemotherapy efficacy
Solution Approach 1:
The patent applies local quality by making the protective effect of silver compounds specific to blood cells rather than universal. The silver compounds exhibit selective affinity or interaction with blood cells, providing protection where needed while maintaining chemotherapy's ability to target and destroy cancer cells, thus resolving the contradiction between blood cell preservation and chemotherapy efficacy
Data Source
AI summary
Compounds and methods for protecting blood cells of a subject are disclosed. One method includes providing a compound including silver particles to a subject and facilitating daily ingestion of the compound by the subject. The compound is provided to the subject and facilitating daily ingestion of the compound by the subject is performed to protect blood cells in the subject. The blood cells can be protected during chemotherapy and may include red blood cells, white blood cells, or both red blood cells and white blood cells.